The use of heavy fuel oil by shipping in the Arctic could have disastrous consequences. Banning this fuel would protect the region’s rich wildlife, improve human health and benefit the climate, writes Sue Libenson.
Despite the encouraging and historic climate agreement at COP 21 in Paris, politicians all over the world argue that quick climate action is too costly. But if they redid the calculation and included co-benefits they would take action now. And they should, argues Christian Friis Bach.
When chemicals are considered too dangerous to be tested on humans, animals have long been the answer to some scientific quandaries. The EU project ToxRisk will act as Europe's flagship for safety assessments that do not require the use of animals. EURACTIV Germany reports.
A report by the EU’s disease prevention agency says the risk of Europeans being affected by infectious diseases brought by refugees remains low, but recommends that countries should be prepared to respond to such health threats.
Unused pharmaceuticals, which end up in the environment, such as in groundwater, pose a major threat to public health and the environment, by leading to the development of antimicrobial resistance (AMR) in humans.
The European Parliament overwhelmingly rejected the Commission's plans to allow the recycling of PVC plastics containing DEHP, a hormone disruptor banned in the EU since February 2015. Our partner Journal de l'Environnement reports.
Panagiotis Kouroumplis, Minister for Health and Social Solidarity in Alexis Tsipras' government, has accused EU Health Commissioner Vytenis Andriukaitis of damaging the bloc’s image by ignoring his invitation to visit Greek islands. EURACTIV Greece reports.
When world leaders meet in September to adopt a set of Sustainable Development Goals, the Bill and Melinda Gates Foundation will make a strong case that health goals should be a top priority, writes Bill Gates.
French doctors prescribe more patented statins than their European counterparts. The country’s health service spends €1.2 billion on statins every year, double the budget of some European countries. EURACTIV France reports.